KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
15,510
+240 (1.57%)
Last updated: Jun 16, 2025
KOREA PHARMA Market Cap
KOREA PHARMA has a market cap or net worth of 168.62 billion as of June 17, 2025. Its market cap has decreased by -19.52% in one year.
Market Cap
168.62B
Enterprise Value
157.10B
Revenue
81.78B
Ranking
n/a
PE Ratio
56.43
Stock Price
15,510.00
Market Cap Chart
Since August 10, 2020, KOREA PHARMA's market cap has decreased from 183.78B to 168.62B, a decrease of -8.25%. That is a compound annual growth rate of -1.76%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 16, 2025 | 170.04B | 1.83% |
Dec 30, 2024 | 166.98B | -35.26% |
Dec 28, 2023 | 257.94B | 10.51% |
Dec 29, 2022 | 233.40B | -55.92% |
Dec 30, 2021 | 529.52B | 118.69% |
Dec 30, 2020 | 242.13B | 31.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 381.06T |
SK hynix | 162.58T |
Samsung Biologics | 72.53T |
LG Energy Solution | 69.26T |
Hanwha Aerospace | 44.59T |
Hyundai Motor Company | 43.49T |
HD Hyundai Heavy Industries | 37.95T |
Kia Corporation | 37.89T |